Oral oncology
Perioperative pembrolizumab and the changing paradigm of adjuvant therapy in head and neck squamous cell carcinoma: the case of T1-2, pN1.
Giancarlo Tirelli, Paolo Boscolo-Rizzo
Published: 202510.1016/j.oraloncology.2025.107770
No abstract available for this study.